Qualigen-Logo-Tag.png
Qualigen Therapeutics CEO Michael Poirier Provides Letter to Shareholders
22 févr. 2022 09h15 HE | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers...